Collectively, these results demonstrate that 164B8 is a novel Pin1-targeting agent that effectively induces Pin1 degradation both in cell and in vivo (in tumor and surrounding tissues) and contributes to a significant reduction in peritoneal metastases in our mouse model of metastatic pancreatic cancer. This evidence concerns the gene PIN1 and pancreatic neoplasm.